Sandra Levy
ARTICLES BY THIS AUTHOR
- 5/13/2020
Gilead strikes deal with 5 generic firms to expand remdesivir supply
Gilead has inked deals with Cipla, Ferozsons Laboratories, Hetero Labs, Jubilant Lifesciences and Mylan to manufacture remdesivir for distribution in 127 countries. - 5/13/2020
CVS Health to open 1,000 COVID-19 drive-thru test sites by end of May
CVS Health expects to have up to 1,000 drive-thru COVID-19 testing site locations by the end of May, with the goal of processing up to 1.5 million tests per month. - 5/13/2020
NCPA joins push for additional economic recovery assistance
NCPA is joining the America’s Recovery Fund Coalition, which is advocating for longer-term federal support for businesses and pharmacies. - 5/13/2020
HRG, PHT complete small dispenser DSCSA pilot study
The Drug Supply Chain Security Act pilot study underscored that most pharmacists were unaware of many of the requirements and needed assistance in carrying out best practice and process implementation. - 5/12/2020
California now allowing pharmacist testing for COVID-19
California's Department of Consumer Affairs is issuing a waiver authorizing pharmacists to order and administer COVID-19 tests, drawing praise from industry organizations. - 5/12/2020
Survey: Specialty pharmacists report administrative delays to treatment
A Surescripts survey finds that nearly two-thirds of specialty pharmacists report spending more than 15 minutes on the phone to fill one prescription. - 5/12/2020
Bartell Drugs promotes Beebe to lead merchandising, supply chain
Brent Beebe will be responsible for setting Bartell's strategic direction and for maximizing execution of merchandising, store development and supply chain. - 5/12/2020
NACDS chairman's gavel exchange goes virtual
Via video conference, Walgreens' Richard Ashworth accepted the NACDS chairman's gavel from Wakefern's Chris Lane, who served as chairman last year. - 5/11/2020
FDA approves Zydus Cadila's generic Exjade
Zydus Cadila’s generic Exjade is available in dosage strengths of 125 mg, 250 mg and 500 mg. - 5/11/2020
Fresenius Kabi debuts generic Mycamine
Fresenius Kabi’s first-to-market generic Mycamine provides a cost-effective option for treating certain infections.
